Generation of cDNA constructs
A cDNA clone encoding full length human DSC2a sequence (kindly provided by Prof. W.
Franke, German Cancer Research Center, Heidelberg, Germany) was used as template for PCR amplification with Phusion (NEB). The wild-type (WT) sequence of full length DSC2a was cloned into pEGFP-N1 (Clontech) using HindIII and BamHI restriction sites, and into pCDNA3 (Invitrogen) using BamHI and NotI restriction sites. The mutations were introduced into the pCDNA3 and pEGFP-N1 constructs with the QuikChange mutagenesis kit The pCDNA3 constructs coded for the human DSC2 proteins without any additional amino acids; these proteins could be detected with DSC2 antibodies (which do not cross-react with endogenous mouse or rat DSC2 protein). To distinguish the transfected human protein from endogenous DSC2 in COS-1 cells and also for ease of detection, a green fluorescent protein (GFP)-tag was fused to the C-terminus of the DSC2a constructs (pEGFP-N1 constructs) in case of DSC2a WT, R203C and T275M. This tag did not interfere with processing, localization or binding properties of DSC2a WT in any of the assays ( Figure S2 and data not shown, see also Human DSP-NTP (amino acids (aa) 1-584) 4 was cloned into pEGFP-N1 using HindIII and BamHI restriction sites.
SDS-PAGE, Western blotting
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), Western blotting on nitrocellulose (Protran, Sigma) and immunodetection were performed using standard techniques as described 5 . For signal detection with enhanced chemoluminescence, the SuperSignal West Dura and SuperSignal West Pico reagents (Pierce) and Amersham Hyperfilm ECL films (GE Healthcare) were used. Quantification of blots was done with ImageJ software.
GST-pulldown assays using GST-fusion proteins expressed in mammalian cells
GST-pulldown buffer consisted of 0.5 % NP-40, 20 mM Tris/HCl pH 7.5, 120 mM sodium chloride, 1 mM dithiothreitol, 1 mM sodium ortho-vanadate and protease inhibitors.
COS-1 cell were transfected with 7.5 micrograms of each pEBG construct alone in 100 mm dishes (to assay binding to endogenous PG and PKP2). Alternatively, the pEBG constructs were transfected together with the DSP-NTP construct, using 5 micrograms of DNA each. After 48 h, the transfected COS-1 cells were harvested, lysed in GST-pulldown buffer for 20 min on ice, and extracts clarified by centrifugation at 50,000 g at 4°C for 15 minutes. GST-pulldown assays were performed by addition of glutathione-sepharose for 1 h on ice and washed, eluted and analyzed as described.
Co-immunoprecipitations
For immuno-precipitation experiments COS-1 cells transfected with full length DSC2 were lysed in ice-cold IP-buffer (0.5 % NP-40, 1 % Triton X-100, 20 mM Tris/HCl pH 7.6, 2 mM EDTA, 138 mM sodium chloride, 5 % glycerol, 5 mM dithiothreitol, 1 mM sodium orthovanadate and protease inhibitors, Roche) and incubated on ice for 60 minutes. After clarifying, immunoprecipitations were performed using 1 µg anti-DSC2/3 (Zymed) in the presence of 1 % bovine serum albumin. Immuno-complexes were purified with Protein G sepharose (Sigma), washed three times with IP-buffer and the bound proteins eluted and analyzed as above. 
Indirect immunofluorescence of transiently transfected cells and confocal microscopy

Histological and Immuno-histochemical analysis of myocardial tissue
Myocardial specimens from patient 55.2 obtained at autopsy and from three age-matched individuals with no clinical history or pathological evidence of heart disease (controls) were subjected to the same staining protocols: Specimens were fixed in 10% non-buffered formalin, embedded in paraffin, cut in 5μm sections and stained with Masson's trichrome for histological examination. Unstained slide-mounted sections were immunostained as previously described 6 . Briefly: slide-mounted sections were deparaffinised, placed in citrate buffer (10 mmol/l, pH 6.0), and heated in a microwave oven until boiling for 10 min to enhance specific immunostaining. After being cooled to room temperature, the tissue sections were simultaneously permeabilised and blocked by incubating them in PBS containing 0.1% Triton X-100 and 3% normal goat serum. The sections were then incubated with the primary antibody overnight at 4°C, brought to room temperature, washed three times in PBS, and incubated with indocarbocyanine-conjugated goat anti-mouse or anti-rabbit IgGs (Jackson Immunoresearch) for 2 h at 25° C. Immunostained preparations were analyzed by laserscanning confocal microscopy (Sarastro Model 2000, Molecular Dynamics) as previously A -Sequence alignment for the DSC2 R203C and DSC2 T275M mutations. The DSC2 R203
R203C T275M A897fsX900
residue is completely conserved as part of the DRE motif among vertebrate (top), as well as among human desmosomal cadherins (bottom). The DSC2 T275M residue is completely conserved among vertebrates (top), and the desmocollin family (bottom). In other desmosomal cadherins (desmoglein 1-3) , it is always a polar residue, such as arginine or histidine, but never an apolar one (such as methionine). Structurally, this residue T275 is located in the calcium binding pocket between the first and the second cadherin domain 7, 8 .
B -Possible impact of the DSC2 R203 mutation on the domain structure: A structural model of the first cadherin domain of DSG2 was determined by NMR spectroscopy by Sano et al.
(pdb entry 2YQG, DOI:10.2210/pdb2yqg/pdb). In this model, R80 correlates to DSC2 R203.
R80 forms a salt bridge to a conserved aspartic acid residue (D112, which corresponds to D235 in human DSC2, left). A model of an arginine to cysteine mutation (R80C) was generated with PyMol. In this R80C model the salt bridge is abolished, which is thought to have major implications for the overall domain structure, most likely having deleterious consequences on the overall domain structure (right). Figure 1D and Table S1 ), was stained with Masson's trichrome (cardiac myocytes are shown in red, fibrous tissue in blue and fatty infiltrates in white). Fibrofatty replacement of cardiomyocytes is evident in the section, confirming the diagnosis of ARVC at the histopathological level (major criterion, see Table S1 ) 4 -Golgi Apparatus localization dominating.
R203C
B
-Diffuse localization throughout the cytoplasm (not vesicular).
An example for each category is given, scale bar represents 10 micrometer. The patients are numbered according to the pedigrees in Figure 1 , and any known symptoms are listed (VT -ventricular tachycardia, SD -sudden death, 0 -asymptomatic).
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The genotypes for the DSC2 mutations and any variants in desmosomal genes are given.
The clinical evaluation is divided in following categories: Note that all individuals with a "possible" diagnosis of ARVC are clinically normal; however the definite diagnosis of ARVC in a first degree relative is a major criterion, and hence the diagnosis "possible ARVC" is made in these individuals. * -Symptoms are suggestive for coronary heart disease.
